Home ⟩ Insights

Insights

fda

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

U.S. Capitol surrounded by flowering hemp plants

3 min read • August 25, 2026

Comply With What? Hemp Ban Nears; the FDA Leaves Industry Waiting for Answers

Cannabinoid regulation Cannabis marijuana hemp DC politics

8 min read • July 17, 2026

The Next Cannabinoid Framework: What Cannabis Businesses Need To Know Before November

Beyond the Announcement Understanding Federal Cannabis Rescheduling - IgniteIt Cannabis Capital Conference - Chicago - 2026

9 min read • July 13, 2026

The Day After Schedule III: What Cannabis Executives Need To Prepare For Now

5 min read • July 1, 2026

Behind Closed Doors: What Happened in the Opening Days of the DEA Cannabis Hearing

hemp marijuana cannabis thc delta 8 9

8 min read • June 23, 2026

The Delta-8 Reckoning: What FDA Enforcement Means for Hemp THC Brands

cannabis investors rescheduling marijuana

4 min read • May 5, 2026

DEA Registration Window Opens: What Cannabis Operators and Investors Must Do Next

cannabis marijuana healthcare

3 min read • May 3, 2026

Lawmakers Push to Block Cannabis Rescheduling, Hemp THC Ban Looms Ahead of November 12 Cutoff

3 min read • April 29, 2026

New Lawsuit Claims CMS Medicare Cannabis Program Undermines FDA-Approved Drug Development

2048px-Donald_Trump

2 min read • April 23, 2026

Trump Administration Reclassifies Medical Marijuana to Schedule III, Marking Major Federal Policy Shift

3 min read • April 6, 2026

New Hospital Cannabis Laws Are A Step Forward, But Investors Should Temper Expectations

Latest Headlines

4 min read • September 11, 2026

Illinois Approves 37 Adult-Use Dispensaries to Sell Medical Cannabis

3 min read • September 11, 2026

U.S. Cannabis Tax Revenue Climbs 15.7% to $3.55 Billion

7 min read • September 10, 2026

Virginia’s Cannabis Lottery Opens the Market, Capital Determines Who Reaches Opening Day

3 min read • September 10, 2026

Cannabis Operators Keep Schedule III Tax Relief but Lose a Seat in Court

6 min read • September 10, 2026

How a Veteran-Led Cannabis Company Grew 2,342% to Make the Inc. 5000 Twice

5 min read • September 9, 2026

Cannabis Companies Face 15% Loan Rates While 68.1% of Surveyed Hemp Businesses Expect Closure

2 min read • September 9, 2026

Curaleaf Defends Aurora Cannabis Takeover Offer, Challenges Board’s Objections

5 min read • September 8, 2026

How Canopy Growth Is Expanding Beyond Flower in Australia’s 81-Tonne Cannabis Import Market

6 min read • September 8, 2026

Why Exporting Cannabis to Europe Is Harder Than It Looks: Organigram on EU-GMP, Testing and Supply

10 min read • September 7, 2026

Britain Is Finally Ready to Authorize CBD Foods. Europe Could Rewrite the Rules Again

6 min read • September 7, 2026

How EDUN Grew Vape Sales 519% in Colorado’s Shrinking Cannabis Market

3 min read • September 4, 2026

Fatal Oklahoma Cannabis Blast Intensifies Scrutiny Of State Marijuana Regulation

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.